Search

Search Constraints

You searched for: Author/Creator Raetz, Elizabeth A.

Search Results

1. A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1. Issue 6 (August 2016)

2. Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group. (7th April 2019)

3. Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience. Issue 3 (18th December 2020)

4. Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. Issue 19 (1st July 2022)

6. Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity. Issue 3 (21st April 2021)

9. Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932. Issue 13 (1st May 2021)

10. Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. Issue 14 (10th May 2021)